NEUROENDOCRINE TUMOURS ARE MOST FREQUENTLY LOCATED IN THE GASTROINTESTINAL ORGAN SYSTEM OR IN THE LUNGS, BUT THEY MAY OCCASIONALLY BE FOUND IN OTHER ORGANS.CASE: We describe a 56-year old woman suffering from a cardinoid syndrome caused by a large serotonin secreting pituitary tumour. She had for years suffered from episodes of palpitations, dyspnoea and flushing. Cardiac disease had been suspected, which delayed the diagnosis, until blood tests revealed elevated serotonin and chromogranin A in plasma. Somatostatin receptor (SSR) scintigraphy showed a single positive focus in the region of the pituitary gland and MRI a corresponding intra- and suprasellar heterogeneous mass. After pre-treatment with octreotide leading to symptomatic improve...
Herein we report a rare case of a pituitary metastasis from a neuroendocrine tumour mimicking an ade...
The use of octreotide in the symptomatic treatment of patients with neuroendocrine tumours: a single...
A 33-year-old male was diagnosed with a metastatic neuroendocrine carcinoma of uncertain primary. He...
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcino...
A 50-year-old woman is described with a very unusual combination of MEN-1 syndrome with a negative f...
SUMMARY Carcinoid is the most common neuroendocrine tumor. It is primarily localized in the ileum a...
Carcinoid tumors are relatively rare neuroendocrine ma-lignancies most commonly originating from ent...
Grade 3 well-differentiated neuroendocrine tumors (G3 NETs) have been characterized in the pancreas ...
A 57-year-old man presented with clinical features of hypercortisolism and was diagnosed with ACTH-d...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Many gastro-enteropancreatic neuroendocrine tumours (GEP-NETs) secrete biologically active substance...
peer reviewedUncommon but classically described, intestinal carcinoid tumors represent a variety of ...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Carcinoid heart disease was first described in 1954. It develops in over 70% of carcinoid syndrome p...
A 43-year-old man presented with fluctuating symptoms of weight gain, shortness of breath, pretibial...
Herein we report a rare case of a pituitary metastasis from a neuroendocrine tumour mimicking an ade...
The use of octreotide in the symptomatic treatment of patients with neuroendocrine tumours: a single...
A 33-year-old male was diagnosed with a metastatic neuroendocrine carcinoma of uncertain primary. He...
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcino...
A 50-year-old woman is described with a very unusual combination of MEN-1 syndrome with a negative f...
SUMMARY Carcinoid is the most common neuroendocrine tumor. It is primarily localized in the ileum a...
Carcinoid tumors are relatively rare neuroendocrine ma-lignancies most commonly originating from ent...
Grade 3 well-differentiated neuroendocrine tumors (G3 NETs) have been characterized in the pancreas ...
A 57-year-old man presented with clinical features of hypercortisolism and was diagnosed with ACTH-d...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Many gastro-enteropancreatic neuroendocrine tumours (GEP-NETs) secrete biologically active substance...
peer reviewedUncommon but classically described, intestinal carcinoid tumors represent a variety of ...
Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fi...
Carcinoid heart disease was first described in 1954. It develops in over 70% of carcinoid syndrome p...
A 43-year-old man presented with fluctuating symptoms of weight gain, shortness of breath, pretibial...
Herein we report a rare case of a pituitary metastasis from a neuroendocrine tumour mimicking an ade...
The use of octreotide in the symptomatic treatment of patients with neuroendocrine tumours: a single...
A 33-year-old male was diagnosed with a metastatic neuroendocrine carcinoma of uncertain primary. He...